ATE444071T1 - Pharmazeutische zusammensetzungen zur behandlung von hauterkrankungen - Google Patents
Pharmazeutische zusammensetzungen zur behandlung von hauterkrankungenInfo
- Publication number
- ATE444071T1 ATE444071T1 AT06380229T AT06380229T ATE444071T1 AT E444071 T1 ATE444071 T1 AT E444071T1 AT 06380229 T AT06380229 T AT 06380229T AT 06380229 T AT06380229 T AT 06380229T AT E444071 T1 ATE444071 T1 AT E444071T1
- Authority
- AT
- Austria
- Prior art keywords
- skin diseases
- pharmaceutical compositions
- treating skin
- mainly
- treatment
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 208000017520 skin disease Diseases 0.000 title abstract 2
- BFZHCUBIASXHPK-QJSKAATBSA-N 11alpha-hydroxyprogesterone Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H](C(=O)C)[C@@]1(C)C[C@H]2O BFZHCUBIASXHPK-QJSKAATBSA-N 0.000 abstract 1
- ZFMITUMMTDLWHR-UHFFFAOYSA-N Minoxidil Chemical compound NC1=[N+]([O-])C(N)=CC(N2CCCCC2)=N1 ZFMITUMMTDLWHR-UHFFFAOYSA-N 0.000 abstract 1
- 201000004681 Psoriasis Diseases 0.000 abstract 1
- CBGUOGMQLZIXBE-XGQKBEPLSA-N clobetasol propionate Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@H](C)[C@@](C(=O)CCl)(OC(=O)CC)[C@@]1(C)C[C@@H]2O CBGUOGMQLZIXBE-XGQKBEPLSA-N 0.000 abstract 1
- 229960004703 clobetasol propionate Drugs 0.000 abstract 1
- 229910052500 inorganic mineral Inorganic materials 0.000 abstract 1
- 239000011707 mineral Substances 0.000 abstract 1
- 229960003632 minoxidil Drugs 0.000 abstract 1
- 239000000546 pharmaceutical excipient Substances 0.000 abstract 1
- 238000002636 symptomatic treatment Methods 0.000 abstract 1
- 229940088594 vitamin Drugs 0.000 abstract 1
- 229930003231 vitamin Natural products 0.000 abstract 1
- 235000013343 vitamin Nutrition 0.000 abstract 1
- 239000011782 vitamin Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/08—Antiseborrheics
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP06380229A EP1891960B1 (de) | 2006-08-17 | 2006-08-17 | Pharmazeutische Zusammensetzungen zur Behandlung von Hauterkrankungen |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE444071T1 true ATE444071T1 (de) | 2009-10-15 |
Family
ID=37499927
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT06380229T ATE444071T1 (de) | 2006-08-17 | 2006-08-17 | Pharmazeutische zusammensetzungen zur behandlung von hauterkrankungen |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US7671044B2 (de) |
| EP (1) | EP1891960B1 (de) |
| CN (1) | CN101522198B (de) |
| AT (1) | ATE444071T1 (de) |
| AU (1) | AU2006347403A1 (de) |
| BR (1) | BRPI0621966A2 (de) |
| CA (1) | CA2661064A1 (de) |
| DE (1) | DE602006009511D1 (de) |
| DK (1) | DK1891960T3 (de) |
| ES (1) | ES2334381T3 (de) |
| IL (1) | IL197035A0 (de) |
| MX (1) | MX2009001631A (de) |
| PT (1) | PT1891960E (de) |
| RU (1) | RU2432952C2 (de) |
| WO (1) | WO2008020091A1 (de) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2893979B2 (es) * | 2020-08-01 | 2023-02-21 | Mc Zosimo S L | Procedimiento para la obtención de una formulación para el tratamiento de dermatitis inflamatorias y producto obtenido |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5972929A (en) * | 1997-08-21 | 1999-10-26 | Shiseido Co., Ltd. | Quinazolinone derivative, hair growth promoter and external composition for skin using the same |
| WO1999049895A2 (en) * | 1998-03-31 | 1999-10-07 | Johnson And Johnson Consumer Companies, Inc. | Method for increasing the permeability of horny human tissue |
| CA2370565C (en) * | 1999-04-23 | 2008-11-25 | Leo Pharmaceutical Products Ltd. A/S (Lovens Kemiske Fabrik Produktionsaktieselskab) | Dermally applicable vitamin d-containing pharmaceutical compositions |
| ES2188426B1 (es) * | 2001-12-12 | 2004-11-16 | Rosalia Pidal Fernandez | Composicion farmaceutica para el tratamiento de la psoriasis y otras dermopatias. |
| KR20050096953A (ko) * | 2003-02-05 | 2005-10-06 | 갈데르마 리써어치 앤드 디벨로프먼트,에스.엔.씨. | 물의 존재에 민감한 하나 이상의 활성제를 함유하는 반전에멀젼 유형 조성물, 및 미용 및 피부과에서의 그의 용도 |
| WO2006051287A1 (en) * | 2004-11-10 | 2006-05-18 | Arrow International Limited | Composition and method for treatment of alopecia areata |
-
2006
- 2006-08-17 PT PT06380229T patent/PT1891960E/pt unknown
- 2006-08-17 DE DE602006009511T patent/DE602006009511D1/de active Active
- 2006-08-17 EP EP06380229A patent/EP1891960B1/de not_active Not-in-force
- 2006-08-17 DK DK06380229.2T patent/DK1891960T3/da active
- 2006-08-17 ES ES06380229T patent/ES2334381T3/es active Active
- 2006-08-17 AT AT06380229T patent/ATE444071T1/de active
- 2006-08-22 CN CN2006800561118A patent/CN101522198B/zh not_active Expired - Fee Related
- 2006-08-22 BR BRPI0621966-7A patent/BRPI0621966A2/pt not_active IP Right Cessation
- 2006-08-22 CA CA002661064A patent/CA2661064A1/en not_active Abandoned
- 2006-08-22 AU AU2006347403A patent/AU2006347403A1/en not_active Abandoned
- 2006-08-22 WO PCT/ES2006/000483 patent/WO2008020091A1/es not_active Ceased
- 2006-08-22 MX MX2009001631A patent/MX2009001631A/es active IP Right Grant
- 2006-08-22 RU RU2009109356/15A patent/RU2432952C2/ru not_active IP Right Cessation
- 2006-09-14 US US11/521,073 patent/US7671044B2/en not_active Expired - Fee Related
-
2009
- 2009-02-12 IL IL197035A patent/IL197035A0/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU2006347403A1 (en) | 2008-02-21 |
| US7671044B2 (en) | 2010-03-02 |
| IL197035A0 (en) | 2009-11-18 |
| CN101522198B (zh) | 2011-10-05 |
| WO2008020091A8 (es) | 2009-04-02 |
| CN101522198A (zh) | 2009-09-02 |
| US20080045487A1 (en) | 2008-02-21 |
| BRPI0621966A2 (pt) | 2011-12-27 |
| RU2009109356A (ru) | 2010-09-27 |
| PT1891960E (pt) | 2010-01-04 |
| MX2009001631A (es) | 2009-06-19 |
| WO2008020091A1 (es) | 2008-02-21 |
| CA2661064A1 (en) | 2008-02-21 |
| DK1891960T3 (da) | 2010-02-01 |
| ES2334381T3 (es) | 2010-03-09 |
| RU2432952C2 (ru) | 2011-11-10 |
| EP1891960B1 (de) | 2009-09-30 |
| DE602006009511D1 (de) | 2009-11-12 |
| EP1891960A1 (de) | 2008-02-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE449602T1 (de) | Arzneimittel mit dobesilat-calcium zur behandlung und prophylaxe von sehnenerkrankungen | |
| CO6761350A2 (es) | Derivados de 2,3-dihidroimidazo[1,2-c]quinazolina sustituidos con aminoalcoholes que son de utilidad para tratar trastornos hiperproliferativos y enfermedades asociadas a la angiogenesis | |
| EA200701511A1 (ru) | Фармацевтические композиции бендамустина, предназначенные для лиофилизации | |
| ATE361084T1 (de) | Topische pharmazeutische zusammensetzungen mit proanthocyanidinen, glycyrrhetinic säure und telmesteine zur behandlung von dermatitis | |
| EA200601776A1 (ru) | Метадоновые композиции местного действия и способы их применения | |
| BRPI0407662B8 (pt) | derivados do ácido 1-fenilalcanocarboxílico para o tratamento de doenças neurodegenerativas | |
| EP1851237A4 (de) | Pharmazeutische zusammensetzungen zur behandlung oder prävention von knochenerkrankungen | |
| ATE456369T1 (de) | Flibanserin zur behandlung von harninkontinenz und assoziierten erkrankungen | |
| CR10166A (es) | Uso de derivados de sulfamida heterociclo benzo-fusionado para el tratamiento del trastorno bipolar y mania | |
| DE602005021770D1 (de) | Indol-1-yl-essigsäurederivate | |
| IL189104A (en) | Pharmaceutical preparation containing lasalazide or sodium balasalazide for use in the treatment of gastrointestinal disorders. | |
| ECSP066608A (es) | Suspensiones acuosas de ciclesonide para nebulización | |
| EA200602002A1 (ru) | Применение спинозинов для заживления ран | |
| ATE541567T1 (de) | Pharmazeutische zusammensetzung zur prävention und behandlung von metabolischen knochenerkrankungen mit alpha-arylmethoxyacrylat- derivaten | |
| ATE442864T1 (de) | Pharmazeutische zusammensetzung mit einem organopolysiloxan-elastomer und einem lösungsmittel-aktivwirkstoff | |
| ATE444071T1 (de) | Pharmazeutische zusammensetzungen zur behandlung von hauterkrankungen | |
| ATE420089T1 (de) | Substituierte azachinazoline mit antiviraler wirkung | |
| RU2006109966A (ru) | Препарат "янтастим-с" для терапии и профилактики инфекционных заболеваний животных | |
| ATE546137T1 (de) | Pharmazeutische zusammensetzungen zur behandlung von warzen | |
| DK1620116T3 (da) | Anvendelse af cinchona til fremstilling af et l gemiddel, som stimulerer angiogenese | |
| ATE493976T1 (de) | Bakuchiol enthaltende pharmazeutische zusammensetzung zur behandlung von weiblicher osteoporose | |
| PL1700597T3 (pl) | Kompozycja farmaceutyczna do podawania na skórę, zawierająca łącznie ubidekarenon, despantenol oraz chlorheksydynę lub jej farmakologicznie dopuszczalną sól | |
| RU2004104036A (ru) | Композиция для лечебно-профилактического ухода за кожей и лечения кожных заболеваний | |
| ATE411014T1 (de) | Bakuchiol enthaltende pharmazeutische zusammensetzung zur behandlung von weiblichem brustkrebs | |
| UA113771C2 (xx) | Фармацевтична композиція у формі дерматологічної мазі для лікування алергічних і запальних захворювань шкіри |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1891960 Country of ref document: EP |